Lassa virus glycoprotein precursor

Product list
The Old World arenavirus Lassa virus (LASV) is the etiologic agent of the often fatal Lassa hemorrhagic fever (LF). LASV is endemic to West Africa and exhibits a case fatality rate of greater than 50% in hospitalized patients and up to 90% in the third trimester of pregnancy. LASV is an enveloped, negative-stranded RNA virus with an ambisense, bisegmented genome that encodes the following four proteins: the matrix protein (Z), viral polymerase (L), nucleoprotein (NP), and glycoprotein precursor (GPC). GPC is trafficked from the endoplasmic reticulum (ER) through the compartment, where it is heavily N-glycosylated and undergoes processing by the cellular proteases SPase and SKI-1/S1P to produce the mature, prefusion glycoprotein (GP). Each GP monomer consists of the following three noncovalently associated subunits: the stable signal peptide (SSP), the receptor binding subunit (GP1), and the fusion machinery (GP2) (14, 15). Three GP monomers associate on the viral surface to form a trimer that drives viral attachment and cell entry.
Show More Close

Inquiry

LASV GPC-A Specific Neutra™ Antibody (V3S-0923-XY43), Human IgG (CAT#: V3S-0923-XY43)

Target: LASV GPC

Host Species: Human

Target Species: Lassa virus (LASV),

Application: ELISA,BLI,Neut,

Inquiry

LASV GPC-B Specific Neutra™ Antibody (V3S-0923-XY61), Human IgG (CAT#: V3S-0923-XY61)

Target: LASV GPC

Host Species: Human

Target Species: Lassa virus (LASV),

Application: ELISA,BLI,Neut,

Inquiry

LASV GPC Specific Neutra™ Antibody (V3S-0124-XY8), Human IgG (CAT#: V3S-0124-XY7)

Target: LASV GPC

Host Species: Human

Target Species: Lassa virus (LASV),

Application: ELISA,Neut,

For research use only, not directly for clinical use.


banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry